- Home
- NMRA vs ASLE Comparison
NMRA vs ASLE Comparison
Compare NMRA & ASLE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NMRA
- ASLE
- Stock Information
- Founded
- NMRA 2019
- ASLE 2008
- Country
- NMRA United States
- ASLE United States
- Employees
- NMRA N/A
- ASLE N/A
- Industry
- NMRA
- ASLE Industrial Specialties
- Sector
- NMRA
- ASLE Consumer Discretionary
- Exchange
- NMRA Nasdaq
- ASLE Nasdaq
- Market Cap
- NMRA 268.5M
- ASLE 277.0M
- IPO Year
- NMRA 2023
- ASLE N/A
- Fundamental
- Price
- NMRA $1.62
- ASLE $8.90
- Analyst Decision
- NMRA Buy
- ASLE Hold
- Analyst Count
- NMRA 8
- ASLE 2
- Target Price
- NMRA $7.14
- ASLE $7.00
- AVG Volume (30 Days)
- NMRA 931.0K
- ASLE 573.4K
- Earning Date
- NMRA 08-06-2025
- ASLE 08-06-2025
- Dividend Yield
- NMRA N/A
- ASLE N/A
- EPS Growth
- NMRA N/A
- ASLE N/A
- EPS
- NMRA N/A
- ASLE 0.13
- Revenue
- NMRA N/A
- ASLE $350,583,000.00
- Revenue This Year
- NMRA N/A
- ASLE $2.54
- Revenue Next Year
- NMRA N/A
- ASLE $16.24
- P/E Ratio
- NMRA N/A
- ASLE $70.01
- Revenue Growth
- NMRA N/A
- ASLE N/A
- 52 Week Low
- NMRA $0.61
- ASLE $4.53
- 52 Week High
- NMRA $17.19
- ASLE $9.06
- Technical
- Relative Strength Index (RSI)
- NMRA 51.72
- ASLE 80.04
- Support Level
- NMRA $1.56
- ASLE $8.63
- Resistance Level
- NMRA $1.78
- ASLE $9.00
- Average True Range (ATR)
- NMRA 0.12
- ASLE 0.41
- MACD
- NMRA -0.03
- ASLE 0.10
- Stochastic Oscillator
- NMRA 58.97
- ASLE 94.31
About NMRA Neumora Therapeutics Inc.
Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.
About ASLE AerSale Corporation
AerSale Corp is an integrated, diversified leader in aviation aftermarket products and services. It specializes in the sale, lease, and exchange of used aircraft, engines, and components, in addition to providing a broad range of maintenance, repair, and overhaul, and engineering services for commercial aircraft and components. The company operating segment includes Asset Management Solutions and TechOps. It generates maximum revenue from the Asset Management Solutions segment.